Form 8-K - Current report:
SEC Accession No. 0001104659-24-087001
Filing Date
2024-08-08
Accepted
2024-08-08 07:12:26
Documents
15
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421054d1_8k.htm   iXBRL 8-K 27388
2 EXHIBIT 99.1 tm2421054d1_ex99-1.htm EX-99.1 71977
6 GRAPHIC tm2421054d1_ex99-1img002.jpg GRAPHIC 12047
  Complete submission text file 0001104659-24-087001.txt   300125

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20240808.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20240808_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20240808_pre.xml EX-101.PRE 22353
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2421054d1_8k_htm.xml XML 3699
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 241186015
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)